Core Alternative Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33K | Hold |
17
| – | – | ﹤0.01% | 271 |
|
|
2025
Q1 | $1.23K | Hold |
17
| – | – | ﹤0.01% | 271 |
|
|
2024
Q4 | $1.26K | Hold |
17
| – | – | ﹤0.01% | 293 |
|
|
2024
Q3 | $1.12K | Hold |
17
| – | – | ﹤0.01% | 306 |
|
|
2024
Q2 | $1.57K | Hold |
17
| – | – | ﹤0.01% | 273 |
|
|
2024
Q1 | $1.63K | Sell |
17
-310
| -95% | -$29.6K | ﹤0.01% | 266 |
|
|
2023
Q4 | $24.9K | Sell |
327
-37
| -10% | -$2.82K | ﹤0.01% | 208 |
|
|
2023
Q3 | $25.2K | Hold |
364
| – | – | ﹤0.01% | 229 |
|
|
2023
Q2 | $34.3K | Buy |
364
+11
| +3% | +$1.04K | 0.01% | 182 |
|
|
2023
Q1 | $29.2K | Buy |
353
+173
| +96% | +$14.3K | ﹤0.01% | 200 |
|
|
2022
Q4 | $13.4K | Sell |
180
-126
| -41% | -$9.4K | ﹤0.01% | 252 |
|
|
2022
Q3 | $25K | Buy |
306
+24
| +9% | +$1.96K | ﹤0.01% | 200 |
|
|
2022
Q2 | $27K | Buy |
282
+49
| +21% | +$4.69K | 0.01% | 196 |
|
|
2022
Q1 | $27K | Buy |
233
+195
| +513% | +$22.6K | 0.01% | 188 |
|
|
2021
Q4 | $5K | Buy |
+38
| New | +$5K | ﹤0.01% | 182 |
|